Word: giusti
(lookup in dictionary)
(lookup stats)
Dates: during 2000-2009
Sort By: most recent first
(reverse)
...takes for such drug development and rollout. Multiple myeloma is a rare cancer of the bone marrow that sickens about 20,000 Americans each year--precisely the uncommon form of the disease that often falls into the research cracks. The MMRF benefited from the aggressive work of founder Kathy Giusti, a multiple-myeloma survivor and former pharmaceutical executive. When she and her group first raised enough money to start funding research, she faced a feeding frenzy of research applicants. "They will do what they have to do to get grant money. They're desperate," she says...
...grant dollars by adopting an enforced-collaboration model in 2004, linking work at four cancer centers into a consortium managed by PricewaterhouseCoopers and providing them all with patients, tissue samples and a set of targets and goals. "The odds of a cure coming from one center are nil," Giusti says. "You need a mutual fund to fight cancer." From not having a single drug in the pipeline, the MMRF now has 30, half of them in clinical trials. The average lifespan of a multiple-myeloma patient has been extended by three years, to seven...